- Genotyping of genes associated with prion diseases: Identification of genetic variants in animals to assess susceptibility or resistance to prion diseases.
- Genotyping of known mutations related to animal diseases with a genetic origin.
- Genomic and transcriptomic sequencing: Identification of molecular biomarkers in various animal species using advanced technologies such as SNP arrays, RNA-seq, or exosome analysis.
- Gut microbiota studies: Metagenomic analysis to evaluate the impact of microbiota on neurological and neurodegenerative diseases, such as canine idiopathic epilepsy or ovine scrapie.